High-resolution cryo-electron microscopy and supercomputing have now made it possible to analyze in detail the infection mechanisms of coronaviruses. These viruses are notorious for attacking the respiratory tract of humans and animals.
A research team that included scientists from the University of Washington (UW), the Pasteur Institute and the University of Utrecht has obtained an atomic model of a coronavirus spike protein that promotes entry into cells.
Analysis of the model is providing ideas for specific vaccine strategies. The study results are outlined in a recent UW Medicine-led study published in Nature.
These viruses, with their crowns of spikes, are responsible for almost a third of mild, cold-like symptoms and atypical pneumonia worldwide, explained David Veesler, UW assistant professor of biochemistry, who headed the project.
But deadly forms of coronaviruses emerged in the form of SARS-CoV (severe acute respiratory syndrome coronavirus) in 2002 and of MERS-CoV (Middle East respiratory syndrome coronavirus) in 2012 with fatality rates between 10 percent to 37 percent. There are no approved vaccines or antiviral treatments against SARS-CoV or MERS-CoV.
The ability of coronaviruses to attach to and enter specific cells is mediated by a transmembrane spike glycoprotein. It forms trimers decorating the virus surface. Trimers are structures assembled from three identical protein units. The structure the researchers studied is in charge of binding to and fusing with the membrane of a living cell. The spike determines what kinds of animals and what types of cells in their bodies each coronavirus can infect.
Using state of the art, single particle cryo-electron microscopy and supercomputing analysis, Veesler and his colleagues revealed the architecture of a mouse coronavirus spike glycoprotein trimer. They uncovered an unprecedented level of detail. The resolution is 4 angstroms, a unit of measurement that expresses the size of atoms and the distances between them and that is equivalent to one-tenth of a nanometer.
“The structure is maintained in its pre-fusion state, and then undergoes major rearrangements to trigger fusion of the viral and host membranes and initiate infection,” Veesler explained.
The coronavirus fusion machinery is reminiscent of the fusion proteins found in another family of viruses, the paramyxoviruses, which include respiratory syncytial virus (the leading cause of infant hospitalizations and wheezing in children) as well as the viruses that cause measles and mumps. This resemblance means coronavirus, like paramyxovirus fusion proteins could employ similar mechanisms to promote viral entry and share a common evolutionary origin.
The researchers also compared crystal structures of parts of the spike protein in mouse and human coronaviruses. Their findings provide clues as to how the molecular structure of these protein domains might influence which specific animal species the virus is able to infect.
The researchers also analyzed the structure for possible targets for vaccine design and anti-viral therapies. They observed that the outer edge of the coronavirus spike trimer has a fusion peptide – a chain of amino acids – that is involved in viral entry into host cells. The easy accessibility of this peptide, and its expected similarity among a number of coronaviruses, suggests possible vaccine strategies to neutralize a variety of these viruses.
“Our studies revealed a weakness in this family of viruses that may be an ideal target for neutralizing coronaviruses,” Veesler said.
The coronavirus spike protein structure described in this Letter to Nature is expected to resemble other coronavirus spike proteins.
“Therefore, the structure we analyzed in the mouse coronavirus is likely to be representative of the architecture of other coronavirus spike proteins such as those of MERS-CoV and SARS-CoV,” the researchers observed.
The researchers summed up their paper, “Our results now provide a framework to understand coronavirus entry and suggest ways for preventing or treating future coronavirus outbreaks.”
“Such strategies,” Veesler said, “would be applicable to several existing coronaviruses and to emerging future strains of coronavirus that conserve this same structure for entering cells.”